Pooled genome-wide CRISPR screening for basal and context-specific fitness gene essentiality in Drosophila cells

Elife. 2018 Jul 27:7:e36333. doi: 10.7554/eLife.36333.

Abstract

Genome-wide screens in Drosophila cells have offered numerous insights into gene function, yet a major limitation has been the inability to stably deliver large multiplexed DNA libraries to cultured cells allowing barcoded pooled screens. Here, we developed a site-specific integration strategy for library delivery and performed a genome-wide CRISPR knockout screen in Drosophila S2R+ cells. Under basal growth conditions, 1235 genes were essential for cell fitness at a false-discovery rate of 5%, representing the highest-resolution fitness gene set yet assembled for Drosophila, including 407 genes which likely duplicated along the vertebrate lineage and whose orthologs were underrepresented in human CRISPR screens. We additionally performed context-specific fitness screens for resistance to or synergy with trametinib, a Ras/ERK/ETS inhibitor, or rapamycin, an mTOR inhibitor, and identified key regulators of each pathway. The results present a novel, scalable, and versatile platform for functional genomic screens in invertebrate cells.

Keywords: CRISPR-cas systems; D. melanogaster; Drosophila cell lines; MAPK; chromosomes; computational biology; fitness essentiality; gene expression; mTOR; systems biology.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Animals
  • CRISPR-Cas Systems
  • Computational Biology
  • Drosophila / genetics*
  • Drug Interactions*
  • Gene Expression Regulation / drug effects
  • Gene Knockout Techniques
  • Gene Library
  • Genes, Essential*
  • Genetic Fitness*
  • Genome-Wide Association Study*
  • Pharmacogenetics
  • Phenotype
  • Protein Kinase Inhibitors / pharmacology*
  • Pyridones / pharmacology
  • Pyrimidinones / pharmacology
  • Sirolimus / pharmacology

Substances

  • Protein Kinase Inhibitors
  • Pyridones
  • Pyrimidinones
  • trametinib
  • Sirolimus